Reuters logo
BRIEF-Oxford Biomedica says GSK options rare disease candidates
December 18, 2013 / 7:31 AM / in 4 years

BRIEF-Oxford Biomedica says GSK options rare disease candidates

Dec 18 (Reuters) - Oxford BioMedica PLC : * Announces option agreement with GlaxoSmithkline * Grants GSK an option for the development of up to six candidates targeting

rare orphan diseases * Source text

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below